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Objectives: To investigate the prognostic significance of preoperative neutrophil to
lymphocyte ratio (NLR) and the impact of different clinical-pathologic factors in a series
of primary oral squamous cell carcinomas (OSCC).
Materials and Methods: All naive OSCCs treated with upfront surgery between 2000
and 2014 were retrospectively reviewed. Patients with distant metastasis, synchronous
head and neck cancer, immunological disorders, or who had received previous
chemotherapy and/or radiation of the head and neck area were excluded. The main
outcomes were overall (OS), disease-specific (DSS), loco-regional free (LRFS), and
distant metastasis free (DMFS) survivals. Univariate (Kaplan-Meier) and multivariate
(Cox regression model) analysis were performed, and nomograms developed for each
outcome. NLR was analyzed as a continuous variable using restricted cubic spline
multivariable Cox regression models.
Results: One-hundred-eighty-two patients were included. Five-year estimates for LRFS,
DMFS, DSS, and OS were 67, 83.7, 69.5, and 61.2%, respectively. NLR had a complex
influence on survival and risk of recurrence: negative for very low and high values,
while positive in case of intermediate ratios. At univariate analysis, T classification,
7th AJCC stage, nodal metastasis, perineural spread, and lymphovascular invasion
were statistically significant. At multivariate analysis, extranodal extension (ENE) and
perineural spread were the most powerful independent prognostic factors. NLR was an
independent prognosticator for the risk of recurrence. In nomograms, NLR and ENE had
the strongest prognostic effect.
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Conclusions: In OSCC, very low preoperative NLR values have a negative prognostic
impact on survival and recurrence, similarly to high ratios. ENE and perineural spread are
the most important clinical-pathologic prognosticators.
Keywords: nomograms, head and neck cancer, oral cancer, squamous cell carcinoma, neutrophil to lymphocyte
ratio, prognosis, extranodal extension, perineural spread
INTRODUCTION
Oral squamous cell carcinoma (OSCC) accounts for more than
95% of oral tumors and is the eighth most frequent cancer
worldwide, with an estimated incidence of 640,000 new cases per
year (1).
Survival of OSCC has slightly improved over the last 30
years, probably as a consequence of multimodal treatment
spreading. However, intensified therapeutic regimens can result
in significant toxicity and worsen the quality of life of survivors;
thus, the definition of reliable prognostic factors is essential to
properly stratify the risk of the individual patient and avoid
undertreatment as well as unjustified toxicity. For this purpose,
a nomogram is an effective way to combine several variables into
a single user-friendly tool able to predict outcomes of interest for
a given patient.
Recently, a deeper insight on the role of the immune
system in the process of cancerogenesis has shed light on
the possible prognostic significance of markers of immune
activation. Neutrophil to lymphocyte ratio (NLR, i.e., the ratio
between the absolute number of circulating neutrophils and
lymphocytes) is one of the most promising. An increased
count of neutrophils can be considered a marker of tumor-
induced systemic inflammation, while lymphocytopenia may
reflect a condition of immunosuppression. Therefore, NLR
can synthetically render the balance between protumoral
inflammatory status and antitumor immune response, where
high values of the ratio represent a tumor-induced change of the
immune system toward a protumoral pattern.
The negative prognostic impact of high pretreatment NLR
values has been investigated for tumors at different sites (2–
9). Several studies have shown a similar prognostic value of
NLR even for head and neck SCC. Interestingly, the negative
impact of higher NLR on both recurrence rate and cancer-related
death is comparable to classic clinical-pathologic parameters
and is apparently independent of human papilloma virus
status (10–16).
The present study is a retrospective analysis of a cohort of
patients treated for OSCC in an academic tertiary care center. The
aim is to investigate the prognostic significance of preoperative
NLR and the impact of different clinical-pathologic factors, and
combine the most relevant prognosticators into nomograms to
better define the risk profile of an individual patient.
MATERIALS AND METHODS
Patients Cohort
This study was conducted in accordance with the
recommendations of the ethics committee of “Spedali Civili” in
Brescia named “Comitato Etico Provinciale della Provincia di
Brescia.” The protocol (NP-2066-Study WV-H&NCancer) was
approved by the abovementioned ethics committee.
We retrospectively reviewed all patients affected by naive
OSCC who underwent surgical resection of the primary
lesion and synchronous neck dissection (with either an
elective or therapeutic intent) between 2000 and 2014 at
the Unit of Otorhinolaryngology—Head and Neck Surgery
of the University of Brescia, Italy. Exclusion criteria were:
(1) presence of distant metastases and/or synchronous head
and neck SCC; (2) unavailable follow-up (death within 1
month after completion of treatment or impossibility to
have information about the patient status); (3) previous
chemotherapy for any cancer and/or radiotherapy in
the head and neck area; (4) immunological disorders or
immunosuppressed status.
Blood Samples and Clinical-Pathological
Data
Preoperative blood cell counts of all patients were
retrospectively retrieved. NLR was defined as the
absolute neutrophil count divided by the absolute
lymphocyte count. Blood cell counts of a cohort
of non-oncologic patients who underwent nasal
septoplasty between 2013 and 2014 were included as a
control group.
Clinical-pathologic variables analyzed included patient’s
profile, tumor characteristics, nodal status, and adjuvant
treatments. All tumors were classified according to the 7th
edition of the TNM staging system.
Principles of Treatment and Follow-Up
Surgery was always performed upfront with curative
intent. Resection was planned according to the site,
extension, and tumor depth of invasion (DOI). A
purely transoral excision was performed for lesion
with DOI <10mm; conversely, compartmental surgery
with a “pull-through” approach was applied for tongue
and oral floor SCC with DOI >10mm (17). Bone
involvement was managed by marginal or segmental
mandibulectomy in case of cortical or medullary
invasion, respectively.
In case of elective treatment of the neck, the dissection
encompassed levels I-III or I-IV, according to the anatomic
subsite(s) involved by the tumor. If clinical positive nodes
were detected, a comprehensive neck dissection (levels I-V)
was planned.
Adjuvant treatment(s) was discussed case by case in the
multidisciplinary tumor board. In general, photon beam
radiotherapy (60–66Gy with daily fractions of 1.8–2Gy) was
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delivered in case of high-grade tumors, advanced T categories
(pT3-T4a), lymphovascular invasion, perineural spread, and/or
more than 2 positive nodes. Concurrent chemotherapy (cisplatin
100 mg/mq every 3 weeks, or 40 mg/m2 weekly) was
administered in case of positive margins and/or extranodal
extension (ENE).
Follow-up included clinical examination every 2 months
and imaging studies (magnetic resonance [MR] or computed
tomography [CT], and neck ultrasonography [US]) every 4–
6 months during the first 2 years; clinical and radiological
evaluations were subsequently performed every 6 months till the
5th year, and then once yearly. Metastatic spread was ruled out by
total body CT or PET-CT every 6 months during the first 2 years,
and then yearly.
Statistical Analysis
We analyzed 4 survival endpoints (overall survival [OS], disease-
specific survival [DSS], loco-regional free survival [LRFS], distant
metastasis free survival [DMFS]) defined as the time between
surgery and the date of the corresponding event (death for
any cause, cancer related death, locoregional recurrence, distant
metastasis) or last follow-up visit.
Student t-test, Chi-square test, Mann-Whitney test and
Spearman test were used for group comparisons, as appropriate.
Univariate survival curves were estimated using the Kaplan–
Meier method and compared by the Log-rank test. Multivariate
analyses were performed using Cox proportional hazard models.
NLR was modeled as a continuous variable, and its functional
relationship with survival outcomes was evaluated by restricted
cubic spline using four knots (18). In all analyses a significance
level of 5% was used.
To estimate the bivariate distribution of survival times and
NLR levels, we computed a nearest-neighbors estimator using a
rectangular kernel (19, 20). For illustration purposes, we show
the estimated survival curves for low, medium, and high levels
of NLR, determined as the survival curve estimate for the
neighborhood of the smallest, median, and largest values of the
signature, respectively.
The final models were internally validated using non-
parametric bootstrap with 200 resamples. The accuracy of
predictions was evaluated by estimating the model’s calibration
and discrimination as measured by the concordance index (c-
index). The c-index is the probability that for two randomly
selected patients, the patient who experienced the event first has
a higher predicted probability of having the event. Therefore,
a c-index of 0.5 represents agreement by chance alone, while
a c-index of 1 means perfect discrimination. C-index are
reported as naive model estimates, their bootstrap estimates
(average of individual bootstrap estimates) as well as optimism-
corrected estimates.
Calibration curves were drawn by grouping patients with
considering their nomogram-predicted probabilities and plotting
the mean of predicted probabilities for each group with the mean
observed Kaplan–Meier estimate.
SPSS version 23.0, GraphPad Prism and R were used for
statistical analysis.
FIGURE 1 | Frequency distribution of neutrophil to lymphocyte ratio values in
the series.
TABLE 1 | Comparison of blood parameters between OSCC patients and control
group.
Neutrophils p* Lymphocytes p* NLR p*
n 103/uL <0.0001 103/uL 0.017 <0.0001
OSCC 167 4.84 ± 1.68 1.82 ± 0.55 2.89 ± 1.33
Controls 24 3.44 ± 0.66 2.34 ± 0.71 1.62 ± 0.59
*Students t-test.
RESULTS
Demographics, NLR, and
Clinical-Pathologic Variables
One-hundred-eighty-two patients were considered eligible for
the study. Median age was 64 years (range, 26–93) with a slight
male prevalence (male to female ratio= 1.7).
NLR was available for 167 (91.8%) patients, because
preoperative blood cell count could not be retrieved in the
remaining 15. Median value was 2.54 (range, 0.80–7.55).
Frequency distribution of NLR values in the series is depicted
in Figure 1. The control group was composed of 24 patients
who underwent nasal septoplasty. In patients affected by OSCC,
neutrophil count was higher (p < 0.0001), lymphocyte count
lower (p = 0.017), and consequently NLR higher (p < 0.0001)
than in the control group (Table 1).
Clinical-pathologic data are summarized in Table 2. The most
frequently involved subsites were the mobile tongue and floor
of the mouth, accounting for about 75% of the whole series. At
referral, 65.9% of patients presented with advanced disease (7th
AJCC stages III-IV) and 42.3% with a high-grade tumor.
Positivemargins were detected in 17.6% of surgical specimens.
On average, 47 lymph nodes were removed in each neck
dissection. In pN+ patients, the median of positive lymph nodes
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TABLE 2 | Clinical-pathologic features of the series.
Variable N %
Gender Male 115 63.2
Female 67 36.8
Behavioral risk factors None 67 36.8
Alcohol 11 6
Smoke 55 30.2
Smoke and alcohol 43 23.6
Pack/Year <or = 10 65 35.7
>10 70 38.5
Not available 47 25.8
Subsite Tongue 90 49.5
Oral floor 46 25.3
Retromolar trigone 18 9.9
Alveolar crest 18 9.9
Cheek mucosa 7 3.8
Hard palate 2 1.1
Lips 1 0.5
Treatment Surgery 78 42.9
Surgery+RT 61 33.5
Surgery+RT+CHT 43 23.6
pT T1 36 19.8
T2 55 30.2
T3 6 3.3
T4 85 46.7
pN N0 97 53.3
N1 29 15.9
N2a 2 1.1
N2b 42 23.1
N2c 12 6.6
N3 0 0
ENE Absent 43 50.6
Present 42 49.4
AJCC stage I 23 12.6
II 39 21.4
III 16 8.8
IV 104 57.1
Surgical margins Negative 97 53.3
Close (<5mm) 53 29.1
Positive 32 17.6
Grading 1 18 9.9
2 87 47.8
3 77 42.3
Perineural spread Absent 92 50.5
Present 90 49.5
Lymphovascular invasion Absent 131 72
Present 51 28
Bone invasion Absent 149 81.9
Cortical 15 8.2
Medullary 18 9.9
CHT, chemotherapy; ENE, extranodal extension; RT, radiotherapy.
was 2 (range, 1–18); mean andmedian nodal ratios were 0.07 and
0.05, respectively (range, 0.01–0.32). Adjuvant treatment(s) was
administered in 57.1% of patients.
TABLE 3 | Association analysis between neutrophil-to-lymphocyte ratio and
pathological variables; p-value estimated by Mann-Whitney test.
Variables N (%) NLR
median (I-III Q) p
pT T1-2 86 (51) 2.40 (1.85–3.28) 0.036
T3-4 81 (49) 2.70 (2.22–3.68)
7th AJCC stages I-II 58 (35) 2.32 (1.71–3.31) 0.077
III-IV 109 (65) 2.65 (2.12–3.67)
ENE (N+) Absent 40 (52) 2.53 (1.95–3.21) 0.298
Present 37 (48) 2.63 (2.18–3.68)
PNI Absent 83 (50) 2.51 (1.88–3.40) 0.326
Present 84 (50) 2.62 (2.03–3.75)
LVI Absent 122 (73) 2.50 (1.93–3.44) 0.279
Present 45 (27) 2.66 (2.10–3.84)
Bold indicates p values inferior to 0.05 (statistical significant).
FIGURE 2 | Correlation between neutrophil-to-lymphocyte ratio and number
of positive nodes (Spearman test).
Associations between NLR and clinical-pathologic variables
are depicted in Table 3 and Figure 2. Patients with advanced
T classification tended to show higher NLR values, while
no correlations was demonstrated with 7th AJCC stages,
number of positive nodes, ENE, perineural spread, and
lymphovascular invasion.
Oncological Outcomes
Mean follow-up was 54 months (range, 2–163). Overall,
recurrence rate was 39.6%: 42 (23%) local, 37 (20.3%)
regional, and 29 (15.9%) distant relapses were recorded. Thirty-
two (17.6%) patients had multiple recurrences. Seventy-eight
(42.9%) patients died during follow-up; 53 (29.1%) deaths
were cancer-related.
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FIGURE 3 | Overall (A), disease-specific (B), and recurrence-free survival (C) probability according to neutrophil to lymphocyte ratio, analyzed as a continuous variable.
Two and 5-year estimates for LRFS, DMFS, DSS, and OS
were 71.7 and 67%, 87.5 and 83.7%, 81.5 and 69.5%, 76.9 and
61.2%, respectively.
NLR was first studied as a continuous variable in
univariate analysis to investigate its global influence on
survival probabilities, and showed a bimodal prognostic
impact. In each outcome analyzed, it tended to form
a bell-shaped curve with an asymmetric peak. In fact,
an increased risk for death and/or recurrence was
associated with very low and high values of NLR,
while patients with central NLR values (approximately
in between 2 and 4) tended to show better oncologic
outcomes (Figure 3).
Univariate analysis of clinical-pathologic prognosticators
is summarized in Table 4. T classification, 7th AJCC
stage, nodal status, perineural spread, and lymphovascular
invasion were the strongest prognosticators. In particular,
the presence of ENE resulted in a remarkable further
decrease of survival estimates in patients with nodal
metastasis (Figure 4).
We further analyzed the number of positive nodes
(Figure 5) and nodal ratio (Figure 6) as continuous
variables. The curves demonstrate an inverse relationship
between these variables and each outcome analyzed.
In fact, the increase in the number of positive
nodes or in the value of nodal ratio resulted in a
proportionally decreased probability of disease control
and survival.
In multivariate analysis (Table 5), nodal status was the
most powerful independent prognosticator, and the remarkable
worsening of disease control and survival conferred by ENE
was confirmed. Perineural spread was an independent risk factor
for distant metastasis (HR 4.39) and cancer-related death (HR
2.02), but not for local recurrence. The prognostic impact of
NLR on recurrence, as depicted in Figure 3, was independent
of other major clinical-pathological variables (LRFS, p = 0.005;
DMFS, p = 0.046), while it was close to significance for DSS
(p= 0.078).
Lastly, we developed prognostic nomograms for OS
(Figure 7A), DSS (Figure 7B), LRFS (Figure 7C), and DMFS
(Figure 7D) from the results of Cox proportional hazards
regression analysis.
Figure 8 shows the calibration plots for the survival models
(OS, DSS, LRFS, and DMFS), in which the predicted probability
of survival is plotted against the observed data.
Model discrimination was evaluated with the c-index, which
quantifies the level of concordance between the predicted and
observed survivals. The c-index for the final models and their
bootstrap estimates and confidence intervals were 0.71 (95% CI,
0.66 to 0.77), 0.76 (95% CI, 0.68 to 0.81), 0.73 (95% CI, 0.65 to
0.80), 0.81 (95% CI, 0.73 to 0.88) for OS, DSS, LRFS, and DMFS,
respectively. The optimism corrected c-indices generated with
the boostrap validation were 0.68 (95% CI, 0.62 to 0.73), 0.73
(95% CI, 0.67 to 0.80), 0.68 (95% CI, 0.62 to 0.75), 0.76 (95% CI,
0.68 to 0.84) for OS, DSS, LRFS, and DMFS, respectively.
Subgroup Analysis
DOIwas analyzed in the subgroup of tumors originating from the
mobile tongue and oral floor, and was available in 121 out of 136
(88.9%) patients. Mean and median DOI were 13.9 and 12.5mm,
respectively (range, 1–38). Stratification into 3 categories [≤5, 5–
10, and >10mm as recently suggested by the 8th Edition of the
AJCCUICC TNM Staging System (21) for T1, T2, and T3 OSCC]
identified three different classes of risk for distant relapse and
death (Figure 9).
Lastly, we explored the impact of adjuvant treatment(s)
in patients with ENE (n = 42). In univariate analysis, we
compared patients undergoing concurrent chemoradiotherapy
(n = 22) with those who received radiotherapy alone (n = 15).
Five patients were excluded because they did not receive
any adjuvant treatment(s). The two groups were balanced
regarding age, pT and pN categories, margin status, grading,
perineural and lymphovascular invasion (p= n.s.), while patients
undergoing concurrent chemoradiotherapy were significantly
younger (p= 0.003; Supplementary Table 1).
Chemotherapy was associated with a remarkable
improvement of disease control and survival (Figure 10).
In fact, patients who received radiotherapy alone experienced
almost a 3-fold higher risk of cancer-related death (HR 2.78; CI,
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FIGURE 4 | Survival estimates (Kaplan-Meier) according to nodal status.
FIGURE 5 | The influence of number of positive nodes (analyzed as a continuous variable) on overall (A), disease-specific (B), local recurrence-free (C), and distant
metastasis-free (D) survival probability. In all cases, an inverse proportion relationship is evident.
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TABLE 4 | Univariate analysis.
Variable 5 y LRFS 5y DMFS 5y DSS 5y OS
% p % p % p % p
Age <65 61.3 0.598 82.2 0.348 73.7 0.166 67.5 0.030
≥ 65 68.7 86.0 63.8 50.9
Gender Male 71.4 0.025 83.1 0.909 69.4 0.897 58.7 0.465
Female 36 84.4 69.3 65.4
Subsite Tongue-
oral floor
66.6 0.656 84.6 0.374 73.4 0.266 63.5 0.300
TRM-
Alveolar
crest
54.2 76.2 53 47.4
Other 67.5 100 85.7 85.7
pT T1-T2 74.1 0.006 92.1 0.002 79 0.004 70.6 0.003
T3-T4 37 74.5 59 50.6
pN/ENE N0 82.4 <0.0001 93.7 <0.0001 77.4 <0.0001 78 <0.0001
N+/ENE- 26.3 83 63 57.3
N+/ENE+ 0 57.5 35.2 27.8
Stage I-II 88.4 <0.0001 95.9 0.001 92.2 <0.0001 83.5 0.0001
III-IV 51 76.8 57.4 49.3
Surgical margins Negative 66.6 0.455 86.3 0.054 72.4 0.192 65.3 0.063
Positive 53.4 70.7 53.5 41.8
Grading G1 87.2 0.030 88.9 0.335 80.9 0.308 67.5 0.266
G2 66.9 77.8 68 58.5
G3 37.5 88.7 66.4 61.8
Perineural spread Absent 73.4 0.013 92 0.0006 80.1 0.004 68.6 0.079
Present 43.8 74.6 58 53.3
Lymphovascular invasion Absent 64.4 0.216 89.7 0.001 75.6 0.0008 68.6 0.001
Present 66.9 66.1 48.3 38.2
Bone invasion Absent 71.1 0.003 84.1 0.465 73.2 0.057 63.5 0.161
Cortical 62.9 92.9 78.8 65.7
Medullary 0 72.6 39.1 39.1
*Nodal ratio <0.07 56.3 0.206 70.24 <0.0001 58.1 0.023 49.4 0.066
≥ 0.07 39.5 0 29.3 26.9
<0.1 56.2 0.040 67.7 <0.0001 57.7 0.002 49.5 0.009
≥ 0.1 31.2 0 12.8 11.9
*Number of positive nodes 1-2 52.4 0.223 #86.4 0.007 61.8 0.001 55.8 0.001
3-4 53.4 #63.9 42.1 33.7
≥ 5 38.8 #59.3 13.7 11.8
ENE, extranodal extension; N+, node metastasis; RMT, retromolar trigone; *Analysis performed in the subgroup of patients with nodal metastasis (n = 85); # Survival at 2 years.
Bold indicates p values inferior to 0.05 (statistical significant).
1.13-6.84; p = 0.02) resulting in a remarkable decrease of 5-year
DSS (19 vs. 52.8%). A similar trend was found for OS (p= 0.05).
DISCUSSION
The most relevant findings of our study are: (1) NLR displays a
complex influence on survival and risk of recurrence, which is
mostly independent of other clinical-pathological variables: worst
outcomes are associated to low and high values, while better
estimates are found with intermediate ratios; (2) ENE, number
of positive nodes, and perineural spread are the most powerful
clinical-pathologic prognosticators; (3) NLR and ENE display the
strongest prognostic effects in nomograms.
The main strength of our series is its homogeneity in terms
of patient and tumor profiles as well as treatment strategy. All
patients indeed received the same surgical procedure (resection
of the tumor and neck dissection) as primary treatment at
referral in a single center, and adjuvant treatment was planned
according to quite homogeneous indications. Likewise, possible
modifiers of tumor biological aggressiveness (recurrent disease,
synchronous tumors, previous radiotherapy in head and neck,
immunosuppression) were excluded. Therefore, selection biases
of retrospective studies were minimized.
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FIGURE 6 | The influence of nodal ratio (analyzed as continuous variable) on disease-specific (A) and distant metastasis-free (B) survival probability.
TABLE 5 | Multivariate analysis.
LRFS DMFS DSS OS
HR
(95% CI)
p HR
(95% CI)
p HR
(95% CI)
p HR
(95% CI)
p
pT (T3-T4 vs. T1-T2) 1.56
(0.83–2.92)
0.169 2.64
(1.06–6.56)
0.037 1.6
(0.83–3.07)
0.162 1.53
(0.89–2.62)
0.126
pN/ENE pN0 1 1 1 1
pN+
ENE-
3.95
(1.92–8.12)
<0.001 1.77
(0.6–5.23)
0.302 2.64
(1.19–5.83)
0.017 1.76
(0.94–3.3)
0.080
ENE+ 4.08
(1.96–8.48)
<0.001 6.82
(2.62–17.75)
<0.001 5.97
(2.84–12.54)
<0.001 3.83
(2.12–6.94)
<0.001
Perineural invasion 1.26
(0.71–2.24)
0.426 4.39
(1.76–10.95)
0.002 2.02
(1.09–3.73)
0.025 1.47
(0.89–2.41)
0.129
NLR* – 0.005 – 0.046 – 0.078 – 0.176
ENE, extranodal extension; HR, hazard ratio; CI, confidence interval; N+, node metastasis. *Neutrophil to lymphocyte ratio (NLR) was modeled using a restricted cubic spline with 3
knots placed at 10, 50, and 90% quantiles. Bold indicates p values inferior to 0.05 (statistical significant).
Survival estimates compare well with those reported in the
literature (22–25). Recurrences mostly occurred loco-regionally
(31.3%), even though the percentage of distant metastases was
not negligible (15.9%).
NLR has several advantages: it is easily and objectively
measured, cost effective, and, most importantly, always available
before treatment planning.
In accordance with other reports (26, 27), patients
affected by OSCC presented with a significantly different
white cells count than healthy controls: higher neutrophils,
lower lymphocytes, and, consequently, higher NLR.
In a recent report, NLR was found to be significantly
higher in OSCC even compared to non-malignant oral
cavity lesions, suggesting a new tool that might help in
identifying oral cavity lesions at higher risk for harboring
malignancy (28).
In our study, we analyzed NLR as a continuous variable using
restricted cubic spline with four knots in order to avoid any loss
of information about its influence on survival. So far, it has been
mostly dichotomized using the receiver operating characteristic
curve or the median, or even subdivided into tertiles; in a single,
recent paper NLR was studied as a continuous variable after
logarithmic transformation (29). In recent meta-analyses on the
prognostic role of NLR in OSCC, its general interpretation as a
bimodal prognostic factor was confirmed (the higher the value,
the poorer the survival); cut-offs ranged from 1.77 to 5, but most
were around 2.5 (30–32).
Some data in our analysis are new and surprising.
In particular, in each outcome the negative prognostic
influence of very low values of NLR parallels the well-
known impact of high NLR (Figure 3). In nomograms,
the prognostic effect of low NLR is even greater than high
NLR, and is comparable (and sometimes superior) to ENE
(Figure 7). More importantly, it is independent of other
clinical-pathological factors with regards to the risk of
recurrence, suggesting that NLR might be considered as an
adjunctive parameter in the decision-making process for
adjuvant treatments.
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FIGURE 7 | Nomogram for prediction of overall survival (A), disease-specific survival (B), loco-regional free survival (C), and distant metastasis-free survival (D). In a
nomogram, a score on a scale from 1 to 100 is assigned to each covariate based on its predictive contribution to the model. Briefly, the variable that displays the
strongest prognostic effect is given 100 points, and all the others receive a smaller value proportional to their size effect. The total amount of points of the single case
is correlated to survival probability of the individual patient (axis in the bottom of each figure).
This finding is unreported in the head and neck cancer
literature. However, in a recent publication on 1,335 gastric
cancers, Urabe et al. (33) demonstrated a non-linear association
between preoperative NLR and survival outcomes by subdividing
the series into quartiles: Q1 (NLR <1.59) showed poorer
estimates than Q2 (1.59<NLR<2.11) and Q3 (2.11<NLR<2.96),
but better than Q4 (NLR >2.96), depicting an influence of NLR
on survival that is very similar to the one found herein.
The interpretation of this influence of NLR on survival is
challenging, and currently only some speculations can be offered.
First, it is not biased by an unbalanced distribution of NLR
values in the series. In fact, median value of NLR is 2.54, and
the group of patients with NLR inferior to 2 is well represented
(about 27%; Figure 1). In a recent retrospective analysis on 1202
OSCC, Chen et al. (34) found a double cut-off of NLR (1.94
and 3.66). They then divided the population into three groups
at low (<1.94), intermediate (1.94–3.66), and high (>3.66) risk,
which could be considered a sort of surrogate of our approach
to NLR as a continuous variable. Their findings are in contrast
with ours, as they did not recognize any negative influence of
low NLR. However, some differences in patient characteristics
need to be mentioned. In the Chinese study, a higher prevalence
of low stage, N0 patients is evident, and in this subgroup NLR
is significantly lower. Conversely, in our series about 60% of
patients with NLR inferior to the median presented with an
advanced stage tumor. Therefore, a low NLR value might have
a different implication according to tumor stage, and possibly
identify two different steps of tumor-host interaction. In early
stage cancers, a low NLR value may indicate a limited influence
of neoplastic cells on the immune system, similar to healthy
controls who showed a comparable low NLR value. In such a
subset of patients, prognosis is excellent. Conversely, in high stage
tumors very low NLR may be marker of an advanced phase of
immune escape, where the immune system is exhausted by a
prolonged corruption by cancer cells. The different length of live
of neutrophils and lymphocytes may justify from a mathematic
perspective the steady decrease of the ratio: neutrophils count
reduces in a shorter time, while circulating lymphocytes persist,
but with a reduced (or null) antitumoral activity. In this view,
“very low” NLR may be the step forward to “high” NLR, as
also suggested by our nomograms, where the negative prognostic
effect of the former is higher than in the latter. This hypothesis
is supported by the work of Wu et al., who analyzed a series
of 262 cT1-T2N0 OSCCs and found that high NLR (>2.95)
significantly correlated with occult node metastasis, perineural
invasion, and tumor thickness >5mm, while low NLR was
associated with better disease-free, disease-specific, and overall
survival estimates (35).
Finally, it is noteworthy that the absolute count of circulating
neutrophils and lymphocytes is a rough data, and no details
about the subpopulations and activation state of leukocytes are
available. For example, low activation of neutrophils and an
increase in CD4/CD8 ratio have been associated with poorer
survival in OSCCs (26). Likewise, a prevalent activation of
CD4+ Treg lymphocytes can decrease immunosurveillance
and promote a protumoral switch of the immune system
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FIGURE 8 | The calibration plots for the survival models: (A) overall survival; (B) disease-specific survival; (C) loco-regional free survival; (D) distant metastasis free
survival.
FIGURE 9 | The impact of the depth of invasion in the subgroup of oral cancer originating from the mobile tongue and oral floor (n = 136).
in cancer patients (36). Lastly, it would be interesting to
investigate the immunologic infiltrate in the primary lesion
of these patients. Caldeira et al. demonstrated a differential
infiltration of neutrophils and lymphocytes in T1-T2 vs.
T3-T4 OSCCs, with a higher density of neutrophils in
the intratumoral region and higher neutrophil/lymphocyte
ratios in the invasive front of advanced lesions (37). A
very low NLR allegedly correlates with an unfavorable
pattern of tumor infiltrating lymphocytes and/or tumor
infiltrating myeloid cells. Further investigations are warranted
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FIGURE 10 | The impact of adjuvant treatments (radiotherapy alone vs. concurrent chemoradiotherapy) in the subgroup of patients with extranodal extension.
to confirm this trend and clarify the reasons that might
explain it.
Concerning clinical-pathologic factors, the most important
prognosticators were ENE, number of positive nodes, and
perineural spread. The negative impact of ENE has been recently
fully incorporated in the new TNM staging system (21), where
it leads to upstaging of the N category, whatever the size,
number, or laterality of positive node(s). Instead, the number
of positive nodes is probably an underestimated parameter
in the current TNM staging system, since in our analysis it
was indeed extremely effective in describing a proportional
decrease of survival estimates (Figure 5). The well-established
indication to intensify treatment (adjuvant chemoradiation) in
case of ENE is confirmed in our series. In fact, the lack
of chemotherapy administration (because of comorbidities, or
because they were treated in the early study period) had a
detrimental effect on every survival end-point. Even though
the retrospective nature of the study and the low number of
patients in these two subgroups compel one to be cautious, the
remarkable difference in outcomes confirm the current trend
of a wise but more liberal use of chemotherapy in association
with radiotherapy in comorbid patients, and prompt to develop
new strategies to tackle tumor with more ominous prognosis,
such as the integration of immunotherapeutic strategies into the
treatment plan.
Overall, the description of survival probability in the single
patient undoubtedly requires assessment of many different
prognosticators. In this view, the nomogram can be an effective,
quick, and practical tool to favor personalization of treatment and
improve patient counseling.
In our model, NLR showed a prognostic effect comparable to
other major pathological prognosticators. In accordance with our
findings, other published evidence supports NLR as an essential
complement in the thorough definition of tumor risk profile.
Recently, Lee et al. proposed a new prognostic scoring system for
OSCC incorporating the same variables used herein, which was
more effective than the AJCC TNM based model (38). Likewise,
Kao et al. developed a nomogram for OS inOSCC, in which a new
score combining albumin and NLR was shown to increase the
prognostic prediction of the model. Interestingly, in their cohort
a large prevalence of betel-inducedOSCCwas present, suggesting
that NLR may be an effective prognosticator independently from
the specific carcinogenetic process considered (39).
Some limitations of our study should be mentioned. Although
our series had strict inclusion criteria, its limited size may
weaken our observations. If compared to other nomograms for
OSCC proposed in literature (40), our model has the limitation
of including pathological prognosticators, which hinders its
application at referral and suggest its use mostly in the decision-
making for adjuvant treatments. However, this issue is minimized
by the great accuracy provided by current radiological studies,
which can guarantee an excellent correspondence between
clinical and pathological TNM classification, and the common
indication for surgery upfront in the treatment of OSCC.
Even though internal validation was performed to avoid over-
interpretation of data, external validation in a larger and different
cohort is warranted to confirm the reliability and applicability of
our results.
Future research should investigate new prognosticators in
the field of tumor-host interaction, such as the quality and
localization of the immune infiltrate, with the aim to improve
definition of the risk profile of the single patient, and customize
treatment accordingly.
CONCLUSIONS
In OSCC, very low preoperative NLR showed a negative
prognostic impact comparable to its high value. The negative
influence of NLR on the risk of recurrence is independent of other
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major clinical-pathologic prognosticators. In nomograms, NLR
and ENE displayed the greatest prognostic effect.
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